Last Updated : April 15, 2024
Details
| Submission received | March 21, 2024 |
|---|---|
| Clarification: - Submission was voluntarily withdrawn by the Provincial Advisory Group (PAG) on 15-Apr-2024 | |
Details
| Call for patient/clinician input open | March 21, 2024 |
|---|---|
| Call for patient/clinician input closed | May 13, 2024 |
| Submission received | May 01, 2024 |
| Submission accepted | May 15, 2024 |
| Review initiated | May 16, 2024 |
| Draft CADTH review report(s) provided to sponsor for comment | August 20, 2024 |
| Deadline for sponsors comments | August 29, 2024 |
| CDA-AMC review report(s) and responses to comments provided to sponsor | September 26, 2024 |
| Expert committee meeting (initial) | October 09, 2024 |
| Draft recommendation issued to sponsor | October 22, 2024 |
| Draft recommendation posted for stakeholder feedback | October 31, 2024 |
| End of feedback period | November 15, 2024 |
| Clarification: - Reconsideration: major revisions requested by sponsor | |
| Expert committee meeting | February 12, 2025 |
| Final recommendation posted | March 18, 2025 |
| Deadline for sponsor to submit redaction requests on draft CADTH review report(s) | March 13, 2025 |
| CDA-AMC review report(s) posted | - |
Last Updated : April 16, 2025
Details
| Call for patient/clinician input open | 21-Mar-24 |
|---|---|
| Call for patient/clinician input closed | 13-May-24 |
| Submission received | 02-Aug-24 |
| Submission accepted | 19-Aug-24 |
| Review initiated | 20-Aug-24 |
| Draft CADTH review report(s) provided to sponsor for comment | 28-Nov-24 |
| Deadline for sponsors comments | 09-Dec-24 |
| CDA-AMC review report(s) and responses to comments provided to sponsor | 10-Jan-25 |
| Expert committee meeting (initial) | 22-Jan-25 |
| Draft recommendation issued to sponsor | 08-Apr-25 |
| Draft recommendation posted for stakeholder feedback | 17-Apr-25 |
| End of feedback period | 05-May-25 |
Last Updated : April 17, 2025
Details
Review Type: Rapid
Provisional Funding Algorithm |
|
|---|---|
| Draft Report Posted: | 21-Mar-2024 |
| Stakeholder Feedback Deadline: | 28-Mar-2024 |
| Final Report Posted: | 22-May-2024 |
Last Updated : May 22, 2024
Details
| Call for patient/clinician input open | 19-Mar-24 |
|---|---|
| Call for patient/clinician input closed | 13-May-24 |
| Submission received | 27-May-24 |
| Submission accepted | 10-Jun-24 |
| Review initiated | 11-Jun-24 |
| Draft CADTH review report(s) provided to sponsor for comment | 29-Aug-24 |
| Deadline for sponsors comments | 10-Sep-24 |
| CDA-AMC review report(s) and responses to comments provided to sponsor | 10-Oct-24 |
| Expert committee meeting (initial) | 23-Oct-24 |
| Draft recommendation issued to sponsor | 04-Nov-24 |
| Draft recommendation posted for stakeholder feedback | 14-Nov-24 |
| End of feedback period | 28-Nov-24 |
| Final recommendation issued to sponsor and drug plans | 11-Dec-24 |
| Final recommendation posted | 06-Jan-25 |
| Deadline for sponsor to submit redaction requests on draft CADTH review report(s) | 02-Jan-25 |
| CDA-AMC review report(s) posted | 07-Apr-25 |
Last Updated : April 7, 2025
Details
| Call for patient/clinician input open | 19-Mar-24 |
|---|---|
| Call for patient/clinician input closed | 13-May-24 |
| Submission received | 27-May-24 |
| Submission accepted | 10-Jun-24 |
| Review initiated | 11-Jun-24 |
| Draft CADTH review report(s) provided to sponsor for comment | 06-Sep-24 |
| Deadline for sponsors comments | 17-Sep-24 |
| CDA-AMC review report(s) and responses to comments provided to sponsor | 10-Oct-24 |
| Expert committee meeting (initial) | 23-Oct-24 |
| Draft recommendation issued to sponsor | 04-Nov-24 |
| Draft recommendation posted for stakeholder feedback | 14-Nov-24 |
| End of feedback period | 28-Nov-24 |
| Final recommendation issued to sponsor and drug plans | 11-Dec-24 |
| Final recommendation posted | 06-Jan-25 |
| Deadline for sponsor to submit redaction requests on draft CADTH review report(s) | 02-Jan-25 |
| CDA-AMC review report(s) posted | - |
Last Updated : April 7, 2025
Details
| Call for patient/clinician input open | 14-Mar-24 |
|---|---|
| Call for patient/clinician input closed | 14-May-24 |
| Submission received | 10-May-24 |
| Submission accepted | 30-May-24 |
| Clarification: - Submission was not accepted for review on 27 May 2024 | |
| Review initiated | 31-May-24 |
| Draft CADTH review report(s) provided to sponsor for comment | 04-Sep-24 |
| Deadline for sponsors comments | 13-Sep-24 |
| CDA-AMC review report(s) and responses to comments provided to sponsor | 10-Oct-24 |
| Expert committee meeting (initial) | 23-Oct-24 |
| Draft recommendation issued to sponsor | 06-Nov-24 |
| Draft recommendation posted for stakeholder feedback | 14-Nov-24 |
| End of feedback period | 28-Nov-24 |
| Final recommendation issued to sponsor and drug plans | 11-Dec-24 |
| Final recommendation posted | 06-Jan-25 |
| Deadline for sponsor to submit redaction requests on draft CADTH review report(s) | 02-Jan-25 |
| CDA-AMC review report(s) posted | 28-Apr-25 |
Last Updated : April 30, 2025
Details
| Call for patient/clinician input open | March 12, 2024 |
|---|---|
| Call for patient/clinician input closed | May 07, 2024 |
| Submission received | April 19, 2024 |
| Submission accepted | May 06, 2024 |
| Review initiated | May 07, 2024 |
| Draft CADTH review report(s) provided to sponsor for comment | July 22, 2024 |
| Deadline for sponsors comments | July 31, 2024 |
| CDA-AMC review report(s) and responses to comments provided to sponsor | August 29, 2024 |
| Expert committee meeting (initial) | September 11, 2024 |
| Draft recommendation issued to sponsor | September 25, 2024 |
| Draft recommendation posted for stakeholder feedback | October 03, 2024 |
| End of feedback period | October 18, 2024 |
| Final recommendation issued to sponsor and drug plans | October 31, 2024 |
| Final recommendation posted | November 19, 2024 |
| Deadline for sponsor to submit redaction requests on draft CADTH review report(s) | November 15, 2024 |
| CDA-AMC review report(s) posted | April 09, 2025 |
Last Updated : April 15, 2025